10x Genomics, Inc. TXG China — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s china — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s china — revenue?
- 10x Genomics, Inc. (TXG) reported china — revenue of $15.84M in Q1 2026.
- How has 10x Genomics, Inc.'s china — revenue changed year-over-year?
- 10x Genomics, Inc.'s china — revenue decreased by 6.2% year-over-year, from $16.88M to $15.84M.
- What is the long-term trend for 10x Genomics, Inc.'s china — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s china — revenue has grown at a -2.5% compound annual growth rate (CAGR), from $77.9M to $70.26M.
- What does china — revenue mean?
- This metric represents the total gross sales generated from products and services sold within the China geographic region. It serves as a key indicator of the company's market penetration, competitive positioning, and demand for life science technology solutions in this specific territory. Tracking this figure helps investors assess regional growth trends and the impact of local regulatory or economic environments on the company's international performance.